Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations

JY Wu, JY Shih, KY Chen, CH Yang, CJ Yu, PC Yang - Medicine, 2011 - journals.lww.com
Gefitinib is effective in treating advanced non-small cell lung cancer (NSCLC), especially in
Asian patients in whom the prevalence of epidermal growth factor receptor (EGFR) mutation …
被引用次数：44 相关文章

Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations.

JY Wu, JY Shih, KY Chen, CH Yang, CJ Yu, PC Yang - Medicine, 2011 - europepmc.org
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for
epidermal growth factor receptor (EGFR) mutations. - Abstract - Europe PMC Sign in | Create …

Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations

JY Wu, JY Shih, KY Chen, CH Yang, CJ Yu… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Gefitinib is effective in treating advanced non-small cell lung cancer (NSCLC), especially in
Asian patients in whom the prevalence of epidermal growth factor receptor (EGFR) mutation …

[引用][C] Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without Testing for Epidermal Growth Factor Receptor (EGFR) Mutations

JY Wu, JY Shih, KY Chen, CH Yang, CJ Yu, PC Yang - Medicine, 2011 - cir.nii.ac.jp
Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without
Testing for Epidermal Growth Factor Receptor (EGFR) Mutations | CiNii Research CiNii 国立 …